The unified social credit code/registration number of Sichuan Nangle Biotechnology Co., Ltd. is 91510185071405021t, and the enterprise is in the state of opening.
The business scope of Sichuan Nangle Biotechnology Co., Ltd. is: research, development and production: Class III 6866 medical polymer materials and products, large-capacity injections (including blood preservation solution) and small-capacity injections; Research, development and production: Class III 6845 extracorporeal circulation and blood treatment equipment; Engaged in the export business of self-produced products and technologies of enterprises (the production and sales of medical devices and drugs in all the above projects are operated according to the scope, address and validity period approved by the pharmaceutical supervisory and administrative department); Engaged in the import and export business of raw and auxiliary materials, instruments and meters, mechanical equipment, spare parts and technologies needed for the production of this enterprise and its member enterprises (except for commodities and technologies restricted and prohibited by the state). (Projects subject to approval according to law can only be operated after approval by relevant departments). In Sichuan Province, the total registered capital of companies with similar business scope is 6.5438+0.4236 million yuan, and the main capital is concentrated in enterprises with a scale of more than 50 million, with 2 companies. In the province, the registered capital of enterprises is good at present.
See more information and materials of Sichuan Capsule Music Biotechnology Co., Ltd. through Baidu Enterprise Credit.